List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 14 studies with search of:   "Pirfenidone"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
Conditions: Albinism;   Inborn Errors of Metabolism;   Oculocutaneous Albinism;   Platelet Storage Pool Deficiency;   Pulmonary Fibrosis
Interventions: Drug: Pirfenidone (Deskar);   Drug: Pirfenidone
2 Completed Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
Conditions: Fibrosis;   Focal Glomerulosclerosis;   Kidney Failure;   Nephrotic Syndrome;   Proteinuria
Intervention: Drug: Pirfenidone
3 Active, not recruiting Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
4 Active, not recruiting Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
5 Completed Pirfenidone to Treat Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Drug: Pirfenidone
6 Enrolling by invitation Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: pirfenidone
7 Completed Pirfenidone to Treat Kidney Disease in Patients With Diabetes
Conditions: Diabetic Nephropathies;   Diabetes Type 1;   Diabetes Type 2;   Diabetic Kidney Disease
Intervention: Drug: Pirfenidone
8 Recruiting Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes
Conditions: Diabetes Mellitus;   Diabetic Nephropathy
Intervention: Drug: Pirfenidone
9 Completed Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
Condition: Cancer-Related Problem/Condition
Intervention: Drug: pirfenidone
10 Completed Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
11 Active, not recruiting Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
12 Active, not recruiting Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1
Condition: Neurofibromatosis
Intervention: Drug: Pirfenidone
13 Active, not recruiting Pirfenidone for the Treatment of Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
14 Completed Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
Conditions: Uterine Leiomyoma;   Fibroids
Intervention: Drug: Pirfenidone

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services